Our executive leadership combines decades of pharmaceutical expertise, scientific innovation, commercial strategy, and international healthcare governance to guide Citro Pharma's global expansion and improve patient outcomes worldwide.
SIMPLIFYING ACCESS FOR HEALTHIER TOMORROW
Globally experienced biopharmaceutical executive with 25+ years of leadership across biologics, biosimilars, advanced therapeutics, and international healthcare innovation. Having contributed to major biologic development platforms including Human Insulin, EPO, G-CSF, Rituximab, and monoclonal antibodies, he leads CitroPharma's strategic transformation toward next-generation therapeutic innovation, scalable global healthcare solutions, and science-driven pharmaceutical growth.
An accomplished international entrepreneur and investment professional with extensive experience in infrastructure, mining, and global business development. As President of Logoden International, he has led the structuring of complex projects and advised governments, agencies, and financial investment companies across international markets. His experience in investment fund development, corporate governance, and strategic partnerships brings valuable commercial and institutional expertise to CitroPharma.
Highly respected pharmaceutical and public healthcare leader with more than 36 years of experience across healthcare supply chain systems, institutional healthcare management, and pharmaceutical operations. Former CEO of Kenya Medical Supplies Authority (KEMSA) and current Non-Executive Chairperson of Kenya's Pharmacy & Poisons Board, he is internationally recognized for advancing healthcare accessibility, operational governance, and large-scale public health infrastructure across emerging markets.
Accomplished pharmaceutical and medical devices executive with over 40 years of leadership experience across the Middle East and North Africa region. Renowned for driving multinational healthcare expansion, strategic partnerships, and operational excellence, he brings deep regional experience to CitroPharma's growth and commercial presence across MENA markets.
Dynamic healthcare and commercial strategy leader with extensive experience in pharmaceutical sales, regional market expansion, and international business development. Recognized for building strong healthcare partnerships and driving strategic growth initiatives, she works closely with government-linked healthcare projects and pharmaceutical stakeholders across Southeast Asia, supporting CitroPharma's expanding regional presence and long-term commercial strategy.
Esteemed medical doctor, surgeon, academic, and clinical researcher specializing in men's health, clinical pharmacology, and therapeutic sciences. As an Associate Professor and independent scientific researcher, he contributes to evidence-based healthcare innovation and the integration of modern clinical research with scientifically validated therapeutic approaches under internationally aligned medical standards.
Strategic corporate development and investor relations professional with extensive experience in organizational planning, governance coordination, stakeholder engagement, and business expansion initiatives. She supports CitroPharma's long-term corporate strategy, institutional communications, and investor engagement framework while contributing to sustainable business growth and executive decision-making.
Experienced pharmaceutical executive and business leader with extensive expertise in the Iraqi healthcare and pharmaceutical market. As CEO of Amedia Group, he leads strategic pharmaceutical operations spanning regulatory affairs, importation, distribution, market access, commercial development, and international partnerships. He helps strengthen CitroPharma's strategic presence in Iraq through market expansion and institutional relationships.